Status:
COMPLETED
Post Covid-19 Quality of Life After Hospital Discharge in Patients Treated With NIV/C-PAP
Lead Sponsor:
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Conditions:
Quality of Life
Eligibility:
All Genders
18-95 years
Brief Summary
A multicenter longitudinal study with data collection at 4 and 8 months after hospital discharge.
Detailed Description
The study population consisted of patients treated with NIV/CPAP, admitted to the COVID-19 wards of the AO SS Antonio e Biagio and Cesare Arrigo in Alessandria (the promoting center), the Azienda Sani...
Eligibility Criteria
Inclusion
- All patients aged ≥18 years admitted for COVID-19 pneumonia treated with NIV/CPAP, discharged to their home with a negative molecular swab and signed informed consent were included in the study
Exclusion
- Exclusion criteria were set in; patients admitted for COVID-19 pneumonia treated with NIV/CPAP and invasive ventilation and patients with pre-existing cognitive disorders at the hospital admission date.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT05408286
Start Date
November 1 2020
End Date
June 30 2021
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda ospedaliera nazionale SS Antonio e Biagio e Cesare Arrigo
Alessandria, Italy, 15121